NCT04847531Completed
REVEAL-CKD: Prevalence and Consequences of Undiagnosed Chronic Kidney Disease
REVEAL-CKD: A Retrospective, Multinational Observational Study to Determine the Prevalence and Consequences of Undiagnosed Chronic Kidney Disease
Source: ClinicalTrials.gov · Last updated 16 Dec 2024
Brief summary (registry, in English)
This is a retrospective, multinational, non-interventional, observational study. A series of cohort studies will be conducted to assess the prevalence of undiagnosed stage 3 CKD in each region. The study will also assess the current state of CKD management in patients with undiagnosed CKD
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1006361 (actual)
- First submitted
- 29 Mar 2021
- Start date
- 15 Dec 2020
- Primary completion date
- 13 Nov 2023
- Lead sponsor
- AstraZeneca
- Diseases
- Chronic kidney disease
- NCT number
- NCT04847531
What you commit to
- Study type: Observational
- Participants enrolled: 1006361
- From 15 Dec 2020 to the primary completion date, 13 Nov 2023
- 13 sites in 11 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Solid organ transplant before the study index date
- Any evidence of advanced CKD (stage 4, 5) based on CKD diagnostic codes, or renal replacement therapy before the index date
Who the study is looking for
- At least two consecutive eGFR laboratory tests with values ≥30 and \<60 mL/min/1.73 m2 (Stage 3A or 3B) that are \>90 and ≤730 days apart. The index date is the date of the second eGFR measure meeting the criteria for stage 3 CKD
- At least 12 months of continuous presence in the database or registration in the data prior to the first qualifying eGFR (for data sources with information on enrolment)
- Age ≥18 years at index date
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (13)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Research Site Coordinator of this site? Confirm its status | Sydney | Australia | Unknown status |
| Research Site Coordinator of this site? Confirm its status | São Paulo | Brazil | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Kingston | Canada | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Guangzhou | China | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Frankfurt | Germany | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Madrid | Spain | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Boulogne-Billancourt | France | Unknown status |
| Research Site Coordinator of this site? Confirm its status | London | United Kingdom | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Milan | Italy | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Kyoto | Japan | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Ann Arbor | United States | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Cambridge | United States | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Louisville | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.